메뉴 건너뛰기




Volumn 27, Issue 4, 2006, Pages 294-299

Correlation between in vitro and in vivo activity of levofloxacin and moxifloxacin against pneumococcal strains with different susceptibilities to fluoroquinolones

Author keywords

Fluoroquinolone resistant; Levofloxacin; Moxifloxacin; Pneumococcal

Indexed keywords

BACTERIAL PROTEIN; DNA TOPOISOMERASE (ATP HYDROLYSING) A; LEVOFLOXACIN; MOXIFLOXACIN; PROTEIN PARC; PROTEIN PARE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TRAVANIC; UNCLASSIFIED DRUG;

EID: 33646009199     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2005.10.022     Document Type: Article
Times cited : (10)

References (13)
  • 1
    • 2442655167 scopus 로고    scopus 로고
    • Quinolone resistance mechanisms in pneumococci
    • Eliopoulos G.M. Quinolone resistance mechanisms in pneumococci. Clin Infect Dis 38 Suppl. 4 (2004) S350-S356
    • (2004) Clin Infect Dis , vol.38 , Issue.SUPPL. 4
    • Eliopoulos, G.M.1
  • 2
    • 0033053495 scopus 로고    scopus 로고
    • Activities of newer fluoroquinolones against Streptococcus pneumoniae clinical isolates including those with mutations in the gyrA, parC, and parE loci
    • Jorgensen J.H., Weigel L.M., Ferraro M.J., Swenson J.M., and Tenover F.C. Activities of newer fluoroquinolones against Streptococcus pneumoniae clinical isolates including those with mutations in the gyrA, parC, and parE loci. Antimicrob Agents Chemother 43 (1999) 329-334
    • (1999) Antimicrob Agents Chemother , vol.43 , pp. 329-334
    • Jorgensen, J.H.1    Weigel, L.M.2    Ferraro, M.J.3    Swenson, J.M.4    Tenover, F.C.5
  • 3
    • 0034996802 scopus 로고    scopus 로고
    • Evaluation of susceptibility testing to detect fluoroquinolone resistance mechanisms in Streptococcus pneumoniae
    • Richardson D.C., Bast D., McGeer A., and Low D.E. Evaluation of susceptibility testing to detect fluoroquinolone resistance mechanisms in Streptococcus pneumoniae. Antimicrob Agents Chemother 45 (2001) 1911-1914
    • (2001) Antimicrob Agents Chemother , vol.45 , pp. 1911-1914
    • Richardson, D.C.1    Bast, D.2    McGeer, A.3    Low, D.E.4
  • 4
    • 0036136859 scopus 로고    scopus 로고
    • Prevalence of single mutations in topoisomerase type II genes among levofloxacin-susceptible clinical strains of Streptococcus pneumoniae isolated in the United States in 1992 to 1996 and 1999 to 2000
    • Davies T.A., Evangelista A., Pfleger S., Bush K., Sahm D.F., and Goldschmidt R. Prevalence of single mutations in topoisomerase type II genes among levofloxacin-susceptible clinical strains of Streptococcus pneumoniae isolated in the United States in 1992 to 1996 and 1999 to 2000. Antimicrob Agents Chemother 46 (2002) 119-124
    • (2002) Antimicrob Agents Chemother , vol.46 , pp. 119-124
    • Davies, T.A.1    Evangelista, A.2    Pfleger, S.3    Bush, K.4    Sahm, D.F.5    Goldschmidt, R.6
  • 5
    • 0034017776 scopus 로고    scopus 로고
    • Intracellular targets of moxifloxacin: a comparison with other fluoroquinolones
    • Pestova E., Millichap J.J., Noskin G.A., and Peterson L.R. Intracellular targets of moxifloxacin: a comparison with other fluoroquinolones. J Antimicrob Chemother 45 (2000) 583-590
    • (2000) J Antimicrob Chemother , vol.45 , pp. 583-590
    • Pestova, E.1    Millichap, J.J.2    Noskin, G.A.3    Peterson, L.R.4
  • 6
    • 0037035122 scopus 로고    scopus 로고
    • Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia
    • Davidson R., Cavalcanti R., Brunton J.L., et al. Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia. N Engl J Med 346 (2002) 747-750
    • (2002) N Engl J Med , vol.346 , pp. 747-750
    • Davidson, R.1    Cavalcanti, R.2    Brunton, J.L.3
  • 7
    • 2442702754 scopus 로고    scopus 로고
    • Quinolone resistance among pneumococci: therapeutic and diagnostic implications
    • Low D.E. Quinolone resistance among pneumococci: therapeutic and diagnostic implications. Clin Infect Dis 38 Suppl. 4 (2004) S357-S362
    • (2004) Clin Infect Dis , vol.38 , Issue.SUPPL. 4
    • Low, D.E.1
  • 8
    • 33645978968 scopus 로고    scopus 로고
    • National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Fourteenth informational supplement. M100-S14. Villanova, PA: NCCLS; 2004.
  • 9
    • 12344323596 scopus 로고    scopus 로고
    • Bactericidal activity of amoxicillin against non-susceptible Streptococcus pneumoniae in an in vitro pharmacodynamic model simulating the concentrations obtained with the 2000/125 mg sustained-release co-amoxiclav formulation
    • Sevillano D., Calvo A., Gimenez M.J., et al. Bactericidal activity of amoxicillin against non-susceptible Streptococcus pneumoniae in an in vitro pharmacodynamic model simulating the concentrations obtained with the 2000/125 mg sustained-release co-amoxiclav formulation. J Antimicrob Chemother 54 (2004) 1148-1151
    • (2004) J Antimicrob Chemother , vol.54 , pp. 1148-1151
    • Sevillano, D.1    Calvo, A.2    Gimenez, M.J.3
  • 10
    • 0002802112 scopus 로고    scopus 로고
    • Measurement of antibiotics in human body fluids: techniques and significance
    • Lorian V. (Ed), Williams & Wilkins, Baltimore, MD
    • Klassen M., and Edberg S.C. Measurement of antibiotics in human body fluids: techniques and significance. In: Lorian V. (Ed). Antibiotics in laboratory medicine (1996), Williams & Wilkins, Baltimore, MD 230-295
    • (1996) Antibiotics in laboratory medicine , pp. 230-295
    • Klassen, M.1    Edberg, S.C.2
  • 11
    • 33646002599 scopus 로고    scopus 로고
    • European Community. Journal officiel des communautés européennes, 18 décembre. Report L358. Luxembourg: Office des publications officielles des communautés européennes; 1986.
  • 12
    • 0002801170 scopus 로고    scopus 로고
    • Evaluation of antimicrobials in experimental animal infections
    • Lorian V. (Ed), Williams & Wilkins, Baltimore, MD
    • O'Reilly T., Cleeland R., and Squires E.L. Evaluation of antimicrobials in experimental animal infections. In: Lorian V. (Ed). Antibiotics in laboratory medicine (1996), Williams & Wilkins, Baltimore, MD 604-765
    • (1996) Antibiotics in laboratory medicine , pp. 604-765
    • O'Reilly, T.1    Cleeland, R.2    Squires, E.L.3
  • 13
    • 0036733450 scopus 로고    scopus 로고
    • Efficacy and pharmacodynamics of simulated human-like treatment with levofloxacin on experimental pneumonia induced with penicillin-resistant pneumococci with various susceptibilities to fluoroquinolones
    • Croisier D., Chavanet P., Lequeu C., et al. Efficacy and pharmacodynamics of simulated human-like treatment with levofloxacin on experimental pneumonia induced with penicillin-resistant pneumococci with various susceptibilities to fluoroquinolones. J Antimicrob Chemother 50 (2002) 349-360
    • (2002) J Antimicrob Chemother , vol.50 , pp. 349-360
    • Croisier, D.1    Chavanet, P.2    Lequeu, C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.